BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 10685385)

  • 1. Treatment alternatives for spinal cord injury related spasticity.
    Kirshblum S
    J Spinal Cord Med; 1999; 22(3):199-217. PubMed ID: 10685385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries.
    Korenkov AI; Niendorf WR; Darwish N; Glaeser E; Gaab MR
    Neurosurg Rev; 2002 Aug; 25(4):228-30. PubMed ID: 12172730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spasticity following spinal cord injury.
    Rekand T; Hagen EM; Grønning M
    Tidsskr Nor Laegeforen; 2012 Apr; 132(8):970-3. PubMed ID: 22562332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Death after acute withdrawal of intrathecal baclofen: case report and literature review.
    Green LB; Nelson VS
    Arch Phys Med Rehabil; 1999 Dec; 80(12):1600-4. PubMed ID: 10597813
    [No Abstract]   [Full Text] [Related]  

  • 5. Subarachnoid-to-Subarachnoid Shunt for Correction of Nonfunctioning Baclofen Pump in a Severe Case of Chronic Debilitating Post-Spinal Cord Injury Spasticity.
    Bakare AA; Weyhenmeyer J; Lee A
    World Neurosurg; 2018 Feb; 110():26-29. PubMed ID: 29101071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of oral baclofen in the management of spasticity: A rationale for intrathecal baclofen.
    Ertzgaard P; Campo C; Calabrese A
    J Rehabil Med; 2017 Mar; 49(3):193-203. PubMed ID: 28233010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Optimized therapy of spastic syndrome by combination intrathecal baclofen with botulinum toxin].
    Vogt T; Urban PP
    Nervenarzt; 2000 Dec; 71(12):1007-11. PubMed ID: 11139983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the effectiveness of intrathecal baclofen on spasticity in individuals with chronic spinal cord injury: a systematic review.
    McIntyre A; Mays R; Mehta S; Janzen S; Townson A; Hsieh J; Wolfe D; Teasell R
    J Spinal Cord Med; 2014 Jan; 37(1):11-8. PubMed ID: 24089997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal baclofen administration during pregnancy: a case series and focused clinical review.
    Morton CM; Rosenow J; Wong C; Kirschner KL
    PM R; 2009 Nov; 1(11):1025-9. PubMed ID: 19942189
    [No Abstract]   [Full Text] [Related]  

  • 10. The dosage and administration of long-term intrathecal baclofen therapy for severe spasticity of spinal origin.
    Kawano O; Masuda M; Takao T; Sakai H; Morishita Y; Hayashi T; Ueta T; Maeda T
    Spinal Cord; 2018 Oct; 56(10):996-999. PubMed ID: 29895878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: a case report.
    Santamato A; Panza F; Ranieri M; Amoruso MT; Amoruso L; Frisardi V; Solfrizzi V; Fiore P
    J Rehabil Med; 2010 Oct; 42(9):891-4. PubMed ID: 20878052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin.
    Zahavi A; Geertzen JH; Middel B; Staal M; Rietman JS
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1553-7. PubMed ID: 15489386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.
    Draulans N; Vermeersch K; Degraeuwe B; Meurrens T; Peers K; Nuttin B; Kiekens C
    Clin Rehabil; 2013 Dec; 27(12):1137-43. PubMed ID: 23858524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence and management of tolerance in intrathecal baclofen therapy.
    Heetla HW; Staal MJ; Kliphuis C; van Laar T
    Spinal Cord; 2009 Oct; 47(10):751-6. PubMed ID: 19333246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of spasticity in a spinal cord-injured patient with intrathecal morphine due to intrathecal baclofen tolerance--a case report and review of literature.
    Soni BM; Mani RM; Oo T; Vaidyanathan S
    Spinal Cord; 2003 Oct; 41(10):586-9. PubMed ID: 14504619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal baclofen in tetraplegia of spinal origin: efficacy for upper extremity hypertonia.
    Burns AS; Meythaler JM
    Spinal Cord; 2001 Aug; 39(8):413-9. PubMed ID: 11512071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased spasticity from a fracture in the baclofen catheter caused by Charcot spine: case report.
    Ravindra VM; Ray WZ; Sayama CM; Dailey AT
    Arch Phys Med Rehabil; 2015 Apr; 96(4):697-701. PubMed ID: 25461826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional effects of spinal baclofen.
    Müller H
    Przegl Lek; 2007; 64 Suppl 2():1-2. PubMed ID: 17953269
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrathecal baclofen for severe spasticity secondary to spinal cord injury.
    Lewis KS; Mueller WM
    Ann Pharmacother; 1993 Jun; 27(6):767-74. PubMed ID: 8329801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New therapies for spastic movement disorders].
    Benecke R; Patejdl R
    MMW Fortschr Med; 2009 Oct; 151 Suppl 3():118-22. PubMed ID: 20623938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.